论文部分内容阅读
随着冠心病发病率的日益升高,如何更有效地降低由此带来的病死率、病残率日益成为研究和关注的焦点。药物、介入、手术治疗能改善心肌缺血和心衰症状,却无法促使梗死的心肌细胞再生,心脏移植也有极大的局限性。近年来分子生物学和细胞生物工程技术的发展以及对造血干细胞研究认
With the increasing incidence of coronary heart disease, how to reduce the mortality and morbidity caused by it more effectively has become the focus of research and attention. Drugs, interventions, surgical treatment can improve myocardial ischemia and heart failure symptoms, but failed to promote the regeneration of infarcted cardiomyocytes, heart transplantation also has great limitations. In recent years, molecular biology and cell biology engineering technology development and research on hematopoietic stem cell recognition